Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Elan/Endorex joint venture to develop iron-chelating products with Schein

Feb. 24, 2000

Small patient study indicates potential of baclofen in treating alcoholism

Feb. 22, 2000

Ecopipam is able to attenuate the mood-altering and other effects of acute cocaine

Feb. 10, 2000

Antizol granted conditional priority review by Canadian authorities

Feb. 8, 2000

Piperidine, pyrrolidine and pyrroline derivatives selectively affect 5-HT function

Feb. 2, 2000

New series from Lilly affecting serotonergic pathways

Feb. 1, 2000

Naltriben: potential new pharmacotherapeutic for reducing alcohol intake

Jan. 17, 2000

Pharmacological profile of SR-141716A, a selective CB1 antagonist, further characterized

Dec. 29, 1999

Brain cocaine receptor ligands from RTI with favorable properties for pharmaceutical, imaging use

Dec. 28, 1999

New agent for treating cocaine dependency in development at RBI

Dec. 22, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...